U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway

Endometriosis is an aggressive disease. It is the main cause of chronic pelvic pain, dysmenorrhea, and infertility, affecting the well-being of women. This study aimed to explore the role of U0126 and BAY11-7082 in endometriosis (EMs) treatment in rats by targeting the MEK/ERK/NF-?B pathway. The EMs...

Full description

Bibliographic Details
Main Authors: Fang Wang, Yong Mei Li, Ru Yue Li, Yu E. Yang, Meng Wei, Chunfang Ha
Format: Article
Language:English
Published: Mary Ann Liebert 2023-02-01
Series:Women's Health Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/full/10.1089/WHR.2021.0151
_version_ 1797345715335200768
author Fang Wang
Yong Mei Li
Ru Yue Li
Yu E. Yang
Meng Wei
Chunfang Ha
author_facet Fang Wang
Yong Mei Li
Ru Yue Li
Yu E. Yang
Meng Wei
Chunfang Ha
author_sort Fang Wang
collection DOAJ
description Endometriosis is an aggressive disease. It is the main cause of chronic pelvic pain, dysmenorrhea, and infertility, affecting the well-being of women. This study aimed to explore the role of U0126 and BAY11-7082 in endometriosis (EMs) treatment in rats by targeting the MEK/ERK/NF-?B pathway. The EMs model was generated and the rats were divided into model, dimethyl sulfoxide, U0126, BAY11-708, and control groups (Sham operation group). After 4 weeks of treatment, the rats were sacrificed. Compared with model group, U0126 and BAY11-7082 treatment significantly inhibited ectopic lesion growth, glandular hyperplasia, and interstitial inflammation. Compared to control group, PCNA and MMP9 levels were significantly increased in the eutopic and ectopic endometrial tissues of model group; the levels of MEK/ERK/NF-?B pathway proteins also increased significantly. Compared with model group, MEK, ERK, and NF-?B levels decreased significantly after U0126 treatment and NF-?B protein expression decreased significantly after BAY11-7082 treatment, with no significant difference in MEK and ERK levels. The proliferation and invasion activities of eutopic and ectopic endometrial cells also significantly decreased after U0126 and BAY11-7082 treatment. In summary, our results showed that U0126 and BAY11-7082 inhibited ectopic lesion growth, glandular hyperplasia, and interstitial inflammatory response in EMs rats by inhibiting the MEK/ERK/NF-?B signaling pathway.
first_indexed 2024-03-08T11:22:31Z
format Article
id doaj.art-77804fb046584e0fb01d5be669b9d358
institution Directory Open Access Journal
issn 2688-4844
language English
last_indexed 2024-03-08T11:22:31Z
publishDate 2023-02-01
publisher Mary Ann Liebert
record_format Article
series Women's Health Reports
spelling doaj.art-77804fb046584e0fb01d5be669b9d3582024-01-26T06:04:59ZengMary Ann LiebertWomen's Health Reports2688-48442023-02-0141657710.1089/WHR.2021.0151U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B PathwayFang WangYong Mei LiRu Yue LiYu E. YangMeng WeiChunfang HaEndometriosis is an aggressive disease. It is the main cause of chronic pelvic pain, dysmenorrhea, and infertility, affecting the well-being of women. This study aimed to explore the role of U0126 and BAY11-7082 in endometriosis (EMs) treatment in rats by targeting the MEK/ERK/NF-?B pathway. The EMs model was generated and the rats were divided into model, dimethyl sulfoxide, U0126, BAY11-708, and control groups (Sham operation group). After 4 weeks of treatment, the rats were sacrificed. Compared with model group, U0126 and BAY11-7082 treatment significantly inhibited ectopic lesion growth, glandular hyperplasia, and interstitial inflammation. Compared to control group, PCNA and MMP9 levels were significantly increased in the eutopic and ectopic endometrial tissues of model group; the levels of MEK/ERK/NF-?B pathway proteins also increased significantly. Compared with model group, MEK, ERK, and NF-?B levels decreased significantly after U0126 treatment and NF-?B protein expression decreased significantly after BAY11-7082 treatment, with no significant difference in MEK and ERK levels. The proliferation and invasion activities of eutopic and ectopic endometrial cells also significantly decreased after U0126 and BAY11-7082 treatment. In summary, our results showed that U0126 and BAY11-7082 inhibited ectopic lesion growth, glandular hyperplasia, and interstitial inflammatory response in EMs rats by inhibiting the MEK/ERK/NF-?B signaling pathway.https://www.liebertpub.com/doi/full/10.1089/WHR.2021.0151endometriosisU0126BAY11-708MEK/ERK/NF-?B
spellingShingle Fang Wang
Yong Mei Li
Ru Yue Li
Yu E. Yang
Meng Wei
Chunfang Ha
U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
Women's Health Reports
endometriosis
U0126
BAY11-708
MEK/ERK/NF-?B
title U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
title_full U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
title_fullStr U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
title_full_unstemmed U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
title_short U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
title_sort u0126 and bay11 7082 inhibit the progression of endometriosis in a rat model by suppressing the mek erk nf b pathway
topic endometriosis
U0126
BAY11-708
MEK/ERK/NF-?B
url https://www.liebertpub.com/doi/full/10.1089/WHR.2021.0151
work_keys_str_mv AT fangwang u0126andbay117082inhibittheprogressionofendometriosisinaratmodelbysuppressingthemekerknfbpathway
AT yongmeili u0126andbay117082inhibittheprogressionofendometriosisinaratmodelbysuppressingthemekerknfbpathway
AT ruyueli u0126andbay117082inhibittheprogressionofendometriosisinaratmodelbysuppressingthemekerknfbpathway
AT yueyang u0126andbay117082inhibittheprogressionofendometriosisinaratmodelbysuppressingthemekerknfbpathway
AT mengwei u0126andbay117082inhibittheprogressionofendometriosisinaratmodelbysuppressingthemekerknfbpathway
AT chunfangha u0126andbay117082inhibittheprogressionofendometriosisinaratmodelbysuppressingthemekerknfbpathway